Skip to main content

Advertisement

Log in

Rheumatoid arthritis in Burkina Faso: clinical and serological profiles

  • Brief Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The objective of this work was to study the clinical and serological profiles of rheumatoid arthritis in Burkina Faso (West Africa). It is a cross-sectional study conducted from March 2006 to February 2009 in the Internal Medicine Department of the University Hospital Yalgado Ouedraogo. All patients seen in the rheumatologic consultation unit during this period, with rheumatoid arthritis fulfilling the ACR criteria, were routinely selected. The determination of anticyclic citrullinated peptide antibodies (ACPA) was carried out with a computerized method (Elia CCP, Phadia AB, Uppsala, Sweden). Values higher than 10 IU/l were considered positive. Forty-eight cases of rheumatoid arthritis (RA) were recruited throughout the study period among 2,194 (2.2 %) patients. Forty-two files were subjected to the study. There were 34 women and 8 men. The average age was 41.70 ± 13 years with extremes of 22 and 71 years. The average duration of the disease was 86.17 ± 82.01 months with extremes of 8 and 360 months. Rheumatoid factors (RF) were positive in 21 out of 30 patients (70.0%). The determination of ACPA carried out in all the patients was positive in 34 (81%) patients; their average value was 217 IU/l with extremes of 38 and 1,170. RF and ACPA were associated to bones erosions (p = 0.0001). Twenty-two patients were placed on methotrexate, eight on hydroxychloroquine, and three on salazopyrine. Nine were given only NSAIDs or prednisolone. No patients had had a biotherapy agent. The frequency of RA was low in our study compared to other African studies published so far. The particularity of RA cases reported in African series, including ours, is the rarity of extra-articular manifestations of the disease. The severity of the disease at presentation in the rheumatology clinic may be due to their late consultation among other causes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Mijiyawa M (1995) Epidemiology and semiology of rheumatoid arthritis in third world countries. Rev Rhum [Eng Ed] 62:121–126

    CAS  Google Scholar 

  2. Schellekens GA, Visser H, de Jong BAW et al (2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptides. Arthritis Rheum 43:155–163

    Article  PubMed  CAS  Google Scholar 

  3. Cruyssen Vander B, Nogueira L, Van Praet J et al (2008) Do all anti-citrullinated protein/peptide antibody tests measure the same? Evaluation of discrepancy between anti-citrullinated protein/peptide antibody tests in patients with and without rheumatoid arthritis. Ann Rheum Dis 67:542–546

    Article  Google Scholar 

  4. Singwe-Ngandeu M, Finckh A, Bas S, Tiercy JM, Gabay C (2010) Diagnostic value of anti-cyclic citrullinated peptides and association with HLA-DRB1 shared epitope alleles in African rheumatoid arthritis patients. Arth Res Ther 12(2):1–7

    Article  Google Scholar 

  5. Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum 31:315–324

    Article  PubMed  CAS  Google Scholar 

  6. Prevoo ML, van’t Hof MA, Kuper HH et al (1995) Modified disease activity scores that include twenty-eight joints counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48

    Article  PubMed  CAS  Google Scholar 

  7. Fries JF, Spitz P, Kraines RG, Holman HR (1980) Measure of patient outcome in arthritis. Arthrtis Rheum 23:137–145

    Article  CAS  Google Scholar 

  8. Bileckot R, Malonga AC (1998) Rheumatoid arthritis in Congo-Brazzaville. A study of thirty-six cases. Rev Rhum Engl Ed 65:308–312

    PubMed  CAS  Google Scholar 

  9. Bwanahali K, Mbuyi M, Kapita B (1991) Osteoarthritis, gout and rheumatoid arthritis in internal medicine in Kinshasa. Rev Rhum Osteoartic 58:105–111

    CAS  Google Scholar 

  10. Eti E, Sylla M, Daboiko JC et al (2000) Contribution to the study of the rheumatoid arthritis in Ivorian hospitals. About 90 cases. Rev Int Sciences Méd 2(2):71–78

    Google Scholar 

  11. Ntsiba H, Ngandeu-Singwe M, Mbuyi-Muamba JM (2009) Rheumatoid arthritis in central Africa. Epidemiological and clinical aspects [abstract]. Rev Rhum 76:1184–1185

    Google Scholar 

  12. Adelowo OO, Ojo O, Oduenyi I, Okwara CC (2010) Rheumatoid arthritis among Nigerians: the first 200 patients from a rheumatology clinic. Clin Rheumatol 29:593–597

    Article  PubMed  Google Scholar 

  13. Stein M, Davis P (1990) Rheumatic disorders in Zimbabwe; a prospective analysis of patients attending rheumatic diseases clinic. Ann Rheum Dis 49:400–402

    Article  PubMed  CAS  Google Scholar 

  14. Mody G, Meyer O (1989) Rheumatoid arthritis in blacks in South Africa. Ann Rheum Dis 48:69–72

    Article  PubMed  CAS  Google Scholar 

  15. Silman AJ, Ollier W, Holligan S et al (1993) Absence of rheumatoid arthritis in a rural Nigeria population. J Rheumatol 20:622–18

    Google Scholar 

  16. Sany J (2003) Rheumatoid arthritis of the adult. Current Design. Paris:John Libbey Eurotext:5–7.

  17. Adebajo O, Adewale (2002) Immunology and immunogenetics of rheumatological diseases in tropical area. Rev Rhum 69:777–790

    Article  Google Scholar 

  18. Klareskog L, Stolt P, Lundberg K et al (2006) A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 54:38–46

    Article  PubMed  CAS  Google Scholar 

  19. Eswar K (2003) Smoking, gender and rheumatoid arthritis epidemiological clues to etiology: Results from the behavioral Risk Factor Surveillance System. J Bone Spine 70:226–234

    Article  Google Scholar 

Download references

Acknowledgments

We would like to thank Dr. Dieudonné Kameni Ndjilé, Rheumatologist, Hôpital Laquintinie of Douala, (Cameroon) and Mrs Ouédraogo Cécile (Burkina Faso) for the English translation of this manuscript.

Disclosures

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dieu-Donné Ouédraogo.

Additional information

This work was presented as a poster at the 22nd Congress of the French Society of Rheumatology in Paris-La Défense, from November 29 to 2 December 2009.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ouédraogo, DD., Singbo, J., Diallo, O. et al. Rheumatoid arthritis in Burkina Faso: clinical and serological profiles. Clin Rheumatol 30, 1617–1621 (2011). https://doi.org/10.1007/s10067-011-1831-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-011-1831-1

Keywords

Navigation